Core Laboratories Inc.
CLB
$11.18
$0.211.91%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -4.37% | -3.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.37% | -3.84% | |||
| Cost of Revenue | -6.34% | -0.57% | |||
| Gross Profit | 4.68% | -16.50% | |||
| SG&A Expenses | 52.02% | 5.58% | |||
| Depreciation & Amortization | 1.45% | -0.33% | |||
| Other Operating Expenses | -255.20% | 78.05% | |||
| Total Operating Expenses | -2.25% | 0.54% | |||
| Operating Income | -27.63% | -34.91% | |||
| Income Before Tax | -84.28% | -30.85% | |||
| Income Tax Expenses | -57.16% | -13.11% | |||
| Earnings from Continuing Operations | -99.08% | -37.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -237.88% | 74.52% | |||
| Net Income | -102.08% | -36.97% | |||
| EBIT | -27.63% | -34.91% | |||
| EBITDA | -20.27% | -28.64% | |||
| EPS Basic | -102.13% | -38.07% | |||
| Normalized Basic EPS | -38.54% | -46.28% | |||
| EPS Diluted | -102.13% | -38.00% | |||
| Normalized Diluted EPS | -38.54% | -45.27% | |||
| Average Basic Shares Outstanding | -2.09% | 1.81% | |||
| Average Diluted Shares Outstanding | -2.09% | -0.10% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -49.07% | 0.59% | |||